P2U accused of â€˜misleadingâ€™ NHS claims in its advertising
Online distance dispenser Pharmacy2U has been accused once more of using misleading claims in its advertising regarding the benefits it offers the NHS.
The National Pharmacy Association said on Friday September 25 that it had asked the NHS and the GPhC to investigate claims used in some of P2U’s online ads.
The NPA said it believed the claim ‘By using Pharnacy2U, you’re helping the NHS’ “cannot be substantiated”. The organisation also said it regarded as “misleading” P2U’s claim that it has been paid over £9m less than “an average high street pharmacy”.
The NPA believes the latter claim misrepresents the way in which NHS pharmacy fees are distributed, Pharmacy Network News understands.
An ad using the ‘average pharmacy’ claim [pictured] links to a page on the P2U website which breaks down the company’s claims regarding NHS savings, but does not refer to “an average high street pharmacy”.
Ads using the contested claims are visible on the online pharmacy’s Facebook page at the time of publication.
The NPA said it “believes that the claims made by Pharmacy2U may contravene GPhC standards which require advertising to be accurate, truthful and not exploitative of any lack of knowledge among the public”.
In 2018, the Advertising Standards Authority upheld the NPA’s complaint that claims that the claims “Saving… the NHS over £300 million a year on prescription costs” and “better for the NHS” as used in ads by P2U in late 2017 were misleading and had not been substantiated. The online pharmacy was told not to repeat these claims.
Pharmacy2U told PNN it was unable to provide a response to the concerns raised by the NPA last week. The GPhC has been approached for comment.
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Well pilots digital consultation service with GP practices
Well Pharmacy is launching a new pilot service whereby its pharmacists provide digital consultations for minor ailments on behalf of GP practices.
3 Min Article
MHRA says benefits of AZ vaccine far outweigh the risks
Current data suggests that incidence of cerebral blood clots is around 4 per million first doses of the AZ vaccine.
4 Min Article
Government must replenish medicines 'buffer stock' say MPs
Government urged to build up buffer stocks of medicines ahead of second wave of pandemic
2 Min Article
Update your knowledge of erection problems with key learning updates from recent research
4 Min Module
Helping customers treat & care for their scalp
Understanding the causes and symptoms of some common scalp conditions will help you to make a real difference to your customers’ lives. Complete this module to discover self-care and product advice to help ease symptoms and maintain scalp health.
24 Min Module